As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ingredients for next-generation neuroscience and obesity drugs when they ...

As more companies integrate large language models into customer support, analytics, and internal automation, the main concern is no longer “Which model is the m ...

Acquisition adds API security testing to Radware’s comprehensive API security portfolio, extending protection to all stages of the API lifecycleMAHWAH, N.J., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Radware® ...

With plans to expand its domestic active pharmaceutical ingredient (API) production in the U.S., AbbVie will invest $195 million to build a new manufacturing facility in North Chicago, Illinois. This ...